Search

Your search keyword '"Xi, Yuanxin"' showing total 200 results

Search Constraints

Start Over You searched for: Author "Xi, Yuanxin" Remove constraint Author: "Xi, Yuanxin" Search Limiters Full Text Remove constraint Search Limiters: Full Text
200 results on '"Xi, Yuanxin"'

Search Results

1. Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancer

2. PDXNet portal: patient-derived Xenograft model, data, workflow and tool discovery

3. Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes

4. Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

5. Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts.

6. B cells and tertiary lymphoid structures promote immunotherapy response

7. Variations in HPV function are associated with survival in squamous cell carcinoma

9. Transcriptomic, Proteomic, and Genomic Mutational Fraction Differences Based on HPV Status Observed in Patient-Derived Xenograft Models of Penile Squamous Cell Carcinoma

10. Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2–Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology

12. Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells

13. Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets

14. FOXR2 Interacts with MYC to Promote Its Transcriptional Activities and Tumorigenesis

15. A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation

16. Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

17. SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers

18. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications

20. Baseline Correction for NMR Spectroscopic Metabolomics Data Analysis

21. Abstract 6206: Combined inhibition of AXL and ATR enhances replication stress, cell death and immune response in small cell lung cancer

22. Abstract 4525: YAP1 in relapsed pulmonary high-grade neuroendocrine carcinomas (NEC) is associated with CDKN2A loss, intact RB1, EMT and therapeutic vulnerability to MEK1 and CDK4/6 inhibition

24. Mutation-Agnostic Detection of Colorectal Cancer Using Liquid Biopsy-Based Methylation-Specific Signatures

25. Histone modification profiling in breast cancer cell lines highlights commonalities and differences among subtypes

27. KLF5 governs sphingolipid metabolism and barrier function of the skin

28. Abstract 5152: Mutation-agnostic detection of colorectal cancer-specific cell-free DNA using targeted methylation sequencing

30. Abstract 3260: Enhanced lineage plasticity in RTK-independent TKI-resistant EGFR-mutant NSCLC

31. Abstract 3473: Use of DNA methylation from tumor and plasma to identify four major small cell lung cancer subtypes with distinct biology and therapeutic vulnerabilities

33. Mutation-Agnostic Detection of Colorectal Cancer Using Liquid Biopsy-Based Methylation-Specific Signatures.

35. ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression

36. SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation

37. Contextual cues from cancer cells govern cancer-associated fibroblast heterogeneity

38. Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

39. SARS-CoV-2 infection induces EMT-like molecular changes, including ZEB1-mediated repression of the viral receptor ACE2, in lung cancer models

43. Abstract 557: Novel targeted combination therapies active in KRAS mutant non-small cell lung cancer (NSCLC) identified using patient-derived xenografts (PDX)

45. Abstract 2899: Single-cell analyses reveal increasing intratumoral heterogeneity as an essential component of treatment resistance in small cell lung cancer

46. BSMAP: whole genome bisulfite sequence MAPping program

47. Baseline Correction for NMR Spectroscopic Metabolomics Data Analysis

48. Comprehensive Genomic Characterization of Parathyroid Cancer Identifies Novel Candidate Driver Mutations and Core Pathways

49. Enhancer transcription reveals subtype-specific gene expression programs controlling breast cancer pathogenesis

50. YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer

Catalog

Books, media, physical & digital resources